Edition:
United Kingdom

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

11.08USD
7:29pm GMT
Change (% chg)

$0.24 (+2.21%)
Prev Close
$10.84
Open
$10.93
Day's High
$11.08
Day's Low
$10.85
Volume
1,101
Avg. Vol
30,475
52-wk High
$15.75
52-wk Low
$5.48

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Oct 1.13 -0.498
Jul 0.10 -0.507
FY 2017 Apr '17 0.11 -0.440
Jan '17 0.25 -0.998
FY 2016 Sep '16 0.01 -1.268
Jun '16 0.01 -3.907
Mar '16 0.01 -3.513
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jan-18 1 5.40 5.40 5.40 --
Quarter Ending Apr-18 1 5.30 5.30 5.30 --
Year Ending Apr-18 1 12.20 12.20 12.20 --
Year Ending Apr-19 1 14.40 14.40 14.40 --
Earnings (per share)
Quarter Ending Jan-18 1 -0.13 -0.13 -0.13 --
Quarter Ending Apr-18 1 -0.16 -0.16 -0.16 --
Year Ending Apr-18 1 -1.21 -1.21 -1.21 --
Year Ending Apr-19 1 -1.40 -1.40 -1.40 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.10 32.90
P/E High - Last 5 Yrs. -- 40.92 45.97
P/E Low - Last 5 Yrs. -- 23.79 24.37
Beta -- 0.90 0.89
Price to Sales (TTM) 151.44 3.98 5.77
Price to Book (MRQ) 2.63 4.84 5.41
Price to Tangible Book (MRQ) 2.63 5.66 6.98
Price to Cash Flow (TTM) -- 23.02 23.42
% Owned Institutions 80.82 1.25 2.22

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.50
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.33 5.21
Payout Ratio(TTM) -- 45.86 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 1,271.43 3.67 9.24
Sales (TTM) vs TTM 1 Yr. Ago 1,503.45 4.72 5.59
Sales - 5 Yr. Growth Rate -- 10.02 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 87.02 16.64 19.65
EPS (TTM) vs TTM 1 Yr. Ago 75.80 -- --
EPS - 5 Yr. Growth Rate -- 9.82 10.73
Capital Spending - 5 Yr. Growth Rate -- 15.22 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 7.87 2.89 2.97
LT Debt to Equity (MRQ) 0.80 9.91 12.22
Total Debt to Equity (MRQ) 1.55 13.93 16.52
Interest Coverage (TTM) -29.72 36.27 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.11 54.70
Gross Margin - 5 Yr. Avg. -- 52.40 52.42
EBITD Margin (TTM) -4,520.00 -- --
EBITD - 5 Yr. Avg -- 18.51 10.86
Operating Margin (TTM) -4,529.25 14.36 4.64
Operating Margin - 5 Yr. Avg. -- 14.42 6.26
Pre-Tax Margin (TTM) -4,120.21 14.77 5.44
Pre-Tax Margin - 5 Yr. Avg. -- 14.73 6.60
Net Profit Margin (TTM) -4,120.21 11.05 1.76
Net Profit Margin - 5 Yr. Avg. -- 11.07 2.91
Effective Tax Rate (TTM) -- 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.41 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 948,737,542 855,667,832
Net Income/Employee (TTM) -- 111,622,076 100,655,557
Receivable Turnover (TTM) -- 5.62 5.78
Inventory Turnover (TTM) -- 2.58 3.35
Asset Turnover (TTM) 0.01 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -55.70 11.45 10.98
Return on Assets - 5 Yr. Avg. -- 12.98 12.37
Return on Investment (TTM) -60.80 14.90 14.43
Return on Investment - 5 Yr. Avg. -- 16.98 16.18
Return on Equity (TTM) -61.05 16.41 16.13
Return on Equity - 5 Yr. Avg. -- 18.08 17.47
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kalvista Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 68.98%
# of Holders: 31
Total Shares Held: 7,439,240
3 Mo. Net Change: -633,739
# New Positions: 14
# Closed Positions: 5
# Increased Positions: 19
# Reduced Positions: 7
# Net Buyers: 12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.